Clinical Study of a Formulation Containing Phtalox® in Periodontal Disease

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

August 30, 2024

Conditions
Periodontal DiseasesPeriodontitisBone Loss
Interventions
OTHER

Scraping and straightening of the crown and root and rinsing with mouthwashes

Patients will answer a questionnaire about their socioeconomic conditions, and soon after undergoing the examination for bleeding, probing, clinical attachment level, probing depth and plaque index for initial clinical evaluation. Basic periodontal treatment will be carried out with the same operator (blind to the treatments performed), with complete removal of plaque and calculi, prophylaxis with pumice and prophylactic paste and oral hygiene instructions. After basic periodontal treatment, patients will be randomly divided based on a draw with closed, opaque and non-translucent envelopes, into 3 groups according to the supporting treatments: G1 - patients who will receive mouthwashes with saline solution; G2 - patients who will be rinsed with 0.12% chlorhexidine and G3 - patients who will be treated with PHTALOX®.

Trial Locations (1)

Unknown

Unifal-Mg, Alfenas

All Listed Sponsors
lead

Universidade Federal de Alfenas

OTHER